Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
94 Leser
Artikel bewerten:
(0)

Global Contrast Injector Market Analysis & Trends Report 2017 - Industry Forecast to 2025

DUBLIN, October 3, 2017 /PRNewswire/ --

The "Global Contrast injector Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering.

Research and Markets Logo

The Global Contrast Injector Market is poised to grow at a CAGR of around 6.1% over the next decade to reach approximately $6.82 billion by 2025.

Some of the prominent trends that the market is witnessing are it-enabled solutions for contrast media injectors, development of gamma and neutron imaging solutions, high prevalence of cardiovascular and neurological disorders and growth opportunities/investment opportunities.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2014, 2015 revenue estimations are presented for 2016 and forecasts from 2017 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview










3.1 Current Trends

3.1.1 It-Enabled Solutions for contrast media injectors


3.1.2 Development of gamma and neutron imaging solutions


3.1.3 High prevalence of cardiovascular and neurological disorders


3.1.4 Growth Opportunities/Investment Opportunities


3.2 Drivers


3.3 Constraints


3.4 Industry Attractiveness

4 Contrast Injector Market, By Application




4.1 Interventional Radiology


4.2 Interventional Cardiology


4.3 Radiology

5 Contrast Injector Market, By Product




5.1 Consumables


5.1.1.1 Syringes


5.1.1.2 Tubing


5.1.1.3 Injector Heads


5.1.1.3.1.1 Dual Head Injectors


5.1.1.3.1.2 Single Head Injectors


5.1.1.3.1.3 Syringeless Injectors


5.1.1.4 Other Consumables


5.2 Injector Systems


5.2.1.1 CT Injector Systems


5.2.1.2 MRI Injector Systems


5.2.1.3 Angiography Injector Systems


5.2.1.4 Cardiology Injectors


5.3 Accessories

6 Contrast Injector Market, By End User




6.1 Ambulatory surgical centers


6.2 Diagnostics centers


6.3 Hospitals

7 Contrast Injector Market, By Geography

8 Key Player Activities






8.1 Acquisitions & Mergers


8.2 Agreements, Partnerships, Collaborations and Joint Ventures


8.3 Product Launch & Expansions


8.4 Other Activities

9 Leading Companies




9.1 Angiodynamics (Navilyst Medical, Inc)


9.2 Apollo RT Co., Ltd.


9.3 Bayer AG (Medrad Inc.)


9.4 Bracco Imaging S.P.A.


9.5 GE Healthcare


9.6 Guerbet Group


9.7 Nemoto Kyorindo Co., Ltd


9.8 Sino Medical-Device Technology Co., Ltd. (SinoMDT)


9.9 Ulrich GmbH & Co. Kg.


9.10 Vivid Imaging



For more information about this report visit

https://www.researchandmarkets.com/research/n85sxt/global_contrast


Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.